摘要：
2024年10月24日, 北京大学药学院天然药物及仿生药物全国重点实验室张亮仁团队和黄卓团队合作在国际著名期刊Journal of Medicinal Chemistry在线刊登了最新研究成果“Discovery of Potent and Selective Blockers Targeting the Epilepsy-Associated KNa1.1 Channel”。
Supporting:
北京大学药学院天然药物及仿生药物全国重点实验室. 张亮仁团队和黄卓团队在抗KCNT1相关癫痫的先导结构发现取得新进展[J]. 中国药学(英文版), 2024, 33(11): 1090-1091.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center.
The research teams of Prof. Liangren Zhang and Prof. Zhuo Huang have made new progress in the discovery of the lead structure of Epilepsy-Associated KNa1.1 Channel
[J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(11): 1090-1091.
>
>